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ABSTRACT
The mechanism through which oxygenated hypothermic machine perfusion (HMP) improves
viability of human extended criteria donor (ECD) livers is not well known. Aim of this study
was to examine the benefits of oxygenated HMP after static cold storage (SCS). Eighteen
ECD livers that were declined for transplantation underwent ex situ viability testing using nor-
mothermic (37°C) machine perfusion (NMP) after traditional SCS (0-4°C) for 7-9 hours. In the
intervention group (n = 6), livers underwent 2 hours of oxygenated HMP (at 12°C) after SCS
and before NMP. Twelve control livers underwent NMP without oxygenated HMP after SCS.
During HMP, hepatic ATP content increased >15-fold and levels remained significantly higher
during the first 4 hours of NMP in the HMP group, compared to controls. Cumulative bile pro-
duction, as well as biliary secretion of bilirubin and bicarbonate, was significantly higher after
HMP, compared to controls. In addition, the levels of lactate and glucose were less elevated
after HMP compared to SCS preservation alone. In contrast, there were no differences in
levels of hepatobiliary injury markers AST, ALT, LDH, and gamma-GT after 6 hours of NMP.
Hepatic histology at baseline and after 6 hours of NMP revealed no differences in the amount
of ischemic necrosis between both groups. In conclusion, two hours of oxygenated HMP after
traditional SCS restores hepatic ATP levels and improves hepatobiliary function, but does not
reduce (preexisting) hepatobiliary injury in ECD livers.
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INTRODUCTION
One of the greatest challenges in liver transplantation is the shortage of suitable donor livers.
Today, many patients are waiting in vain for a liver transplant, which is often the only success-
ful treatment of their liver failure (1). One way to minimize the shortage of liver donor grafts
for transplantation is the use of extended criteria donor (ECD) livers. However, ECD livers
are in general associated with a higher postoperative risk of early graft failure, compared to
livers from optimal or reference donors (2). Because of this, many ECD livers are declined
for transplantation and an important question is how these livers can be functionally improved
and made suitable for transplantation.
During the last decade, machine perfusion (MP) has been receiving increasing attention as a
promising method to reduce preservation injury, compared to the traditional method of static
cold storage (SCS) (3-5). A short period of MP after SCS (end-ischemic MP) has been sug-
gested to reduce the risk of early graft dysfunction after transplantation [6]. In particular ECD
livers, which have a higher risk of early graft failure due to the preexisting hepatocellular injury
and dysfunction, could potentially benefit from end-ischemic MP during organ preservation
(6).
End-ischemic MP can be performed at different temperatures. Hypothermic machine perfu-
sion (HMP; perfusion at 4-12°C), has recently made a first step into clinical practice. Guarrera
et al. (7,8) and Dutkowski et al. (9) have described successful application of end-ischemic MP
of ECD livers in human liver transplantation. In these studies, livers that first underwent end-
ischemic HMP displayed better graft function compared to matched control livers that did not
undergo end-ischemic HMP. In addition, the incidence of ischemic cholangiopathy, also known
as non-anastomotic biliary strictures (NAS), was lower in the group with end-ischemic HMP
treatment (8,9). Although these results are very promising, knowledge about the mechanisms
through which end-ischemic HMP may improve liver and biliary function of human ECD liver
grafts is limited. The aim of the current study was therefore to assess whether end-ischemic
dual (combined arterial and portal) oxygenated hypothermic machine perfusion (HMP) im-
proves hepatobiliary function and reduces preservation injury of human ECD livers, compared
to traditional SCS preservation alone. In the current study, hepatobiliary viability after tradi-
tional SCS preservation or after SCS followed by 2 hours of HMP was assessed during ex situ
normothermic machine perfusion (NMP) for 6 hours.
MATERIALS AND METHODS
Donor Livers
Between May 2012 and August 2014 eighteen consecutive full size human donor livers were
included in this study. All livers were declined for transplantation within the Eurotransplant re-
gion. The two main reasons for declining were: 1) the combination of donation after circulatory
death (DCD) with advanced donor age; and 2) the combination of DCD or donation after brain
death (DBD) and a high body mass index (suspicion of graft steatosis). In the Eurotransplant
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region, a hepatic biopsy for the evaluation of steatosis is not routinely performed during organ
procurement (10). In most cases, only the combination of BMI, laboratory values, and visual
inspection by the donor surgeon gives information about the possible presence of steatosis.
Therefore, the exact percentage of steatosis is not known when the donor liver is offered for
transplantation and/or research purposes.
The study protocol was approved by the medical ethical committee of University Medical Cen-
ter Groningen (METc 2012.068) and the competent authority for organ donation in the Nether-
lands, the Dutch Transplantation Foundation (NTS). The Eurotransplant donor risk index (ET-
DRI) was calculated for all livers using the method described by Braat et al. (11). During the
study period, the first 12 ECD livers were included in the SCS-only group, which consisted
of NMP viability assessment after traditional SCS preservation. Subsequently, 6 other ECD
livers were included in the HMP group. These liver grafts were exposed to 2 hours of HMP
after the period of traditional SCS preservation. After HMP, these livers underwent 6 hours of
NMP for viability assessment (Figure 1 and 2).
Procurement and Preparation of Donor Liver Grafts
All donor livers were procured by one of the regional multi-organ procurement teams in the
Netherlands using the standard technique of in situ cooling and flush out with preservation
fluid (University of Wisconsin [UW] or histidinetryptophan-ketoglutarate solution [HTK]) at 0°C
to 4°C. In case of DBD, 25,000 units of heparin were administered intravenously before cross
clamping of the supratruncal aorta. In DCD cases, the surgical procedure was not started
until after 5-minute no touch period after declaration of circulatory death. During the flush out
procedure, the same dose of heparin (25,000 units of heparin) was added to the first bag of
preservation solution. All livers were packed in ice-cold preservation solution (UW or HTK),
stored on ice, and transported to our center. Upon arrival in our center, an experienced trans-
plant surgeon performed back table preparation. The portal vein, the supratruncal aorta, and
the bile duct were cannulated, and the graft was prepared for oxygenated machine perfusion
as described previously (12-14).
Donation
Procedure Static Cold Storage
Organ Preservation Viability Assessment
NMP
Donation
Procedure Static Cold Storage NMPHMP
Figure 1. Schematic overview of the study groups to examine the effects of end-ischemic oxygenated
hypothermic machine perfusion (HMP) after static cold storage (SCS)
The group that underwent end-ischemic HMP contained 6 livers. The SCS only group contained 12 livers. In
both groups ex situ normothermic machine perfusion (NMP) was used for viability testing for 6 hours
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Machine Perfusion
Based on the studies of Dutkowski and our previous animal experiments that have demon-
strated that 2 hours of HMP is sufficient to obtain beneficial effects (9,15-17), 2 hours of
HMP was used in this study as well. HMP and NMP were performed using a machine per-
fusion device that includes 2 perfusion circuits, each comprising a rotary perfusion pump, a
membrane oxygenator with integrated heat exchanger and pressure sensor for perfusion of
the portal vein and hepatic artery, respectively (Liver Assist, Organ Assist, Groningen, The
Netherlands). Flow through the hepatic artery was pulsatile, whereas flow through the portal
vein was continuous. The system was both pressure and temperature controlled. During HMP,
portal pressure was set at 4 mmHg, mean arterial at 25 mmHg, and temperature of the per-
fusion fluid was 10°C to 12°C, as described previously.16 The solution was oxygenated with
100% oxygen (1 L/min) resulting in a pO2 between 50 and 80 kPa (375-600 mmHg). During
NMP (37°C), the portal pressure was 11 mmHg, and mean arterial pressure was 70 mmHg.
In contrast to HMP, we oxygenated during NMP with a carbogen mixture of 95% O2 and 5%
Figure 2. Photos of the liver during machine perfusion (MP) experiments
Panel A: In a bowl with melting ice and preservation solution, the liver is prepared for oxygenated hypothermic
machine perfusion (HMP) or normothermic machine perfusion (NMP).
Panel B: Liver perfused with HMP. Panel C: Liver perfused for 30 minutes with NMP. Panel D: Liver perfused for
6 hours with NMP. During MP, the organ chamber is covered with a transparent lid to prevent heat loss and to
maintain a moist environment.
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CO2 (2 L/min), resulting in a pO2 between 50 and 80 kPa (375-600 mmHg). During HMP, livers
were perfused with 3 L of Belzer-UW Machine Perfusion solution (Bridge-to-Life, Ltd. North-
brook, IL). After 2 hours of HMP, the liver graft was disconnected from the perfusion device,
placed in a bowl with cold (0-4°C) UW cold storage solution (Bridge-to-Life, Ltd. Northbrook,
IL), to change the perfusion fluid and prime the perfusion device for NMP. Before NMP, the liver
was flushed with 1 L cold NaCl 0.9% solution, followed by 500 mL warm NaCl 0.9% solution.
Livers were perfused normothermically (37°C) for 6 hours with a perfusion solution based
on heparinized human plasma and red blood cells enriched with nutrients, trace elements,
and antibiotics, as described previously (12-14). Before NMP and every 30 minutes during
NMP, samples from the perfusion fluid were taken for analysis of the blood gas parameters
(pO2, pCO2, sO2, HCO3- , and pH) using an ABL800 FLEX analyzer (Radiometer, Brønhøj,
Denmark). If needed, small amounts of sodium bicarbonate (8.4% solution) were added to
maintain a pH within the physiological range (7.35-7.45) as described previously (12-14).
Assessment of Hepatobiliary Function and Injury
During NMP, flow though the portal vein and hepatic artery and perfusion fluid temperature
was recorded every 10 minutes. Because flow through the liver is dependent of liver mass,
we have calculated the intrahepatic vascular resistance using Ohms law and expressed the
vascular resistance for both the portal vein and hepatic artery as mmHg/mL/ min/kg liver.
Before and every 30 minutes during NMP, samples were taken from the perfusion fluid. Of
each sample, one part was used for analysis for and biochemical parameters (glucose and
lactate) using an ABL800 FLEX analyzer (Radiometer, Brønhøj, Denmark). Another part of
the perfusion fluid sample was centrifuged (2700 g for 5 minutes at 4°C), and the supernatant
was collected and stored at 80°C for determination of aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), lactate dehydrogenase (LDH), and gamma-glutamyl transferase
(gamma-GT), using standard biochemical methods. Bile production was measured gravimet-
rically at 30-minute intervals by weighing Eppendorf tubes in which bile was collected from the
biliary drain. The cumulative bile production was expressed as mL bile/kg liver. The density
of bile was defined as 1 mg/mL. Based on the (cumulative) bile production during NMP, livers
were classified as good or poor functioning using a modification of the experimental analysis
described by Sutton et al. (13). Although Sutton et al. (13) expressed bile production as g/hr,
we expressed bile production as mL/hr/kg liver tissue. Livers were classified as good function-
ing if they met the following criteria: bile production of more than 2 mL/hr/kg during 1.5 to 2.5
hours of NMP and cumulative bile production of more than 5 mL/hr/kg after 2.5 hours of NMP.
Biliary concentration of bicarbonate and pH were measured as markers of biliary epithelial cell
(cholangiocyte) function (18). For this purpose, bile samples were collected under mineral oil
and analyzed immediately using an ABL800 FLEX analyzer (Radiometer, Brønhøj, Denmark).
Biliary concentration of gamma-GT and LDH were measured as markers of biliary epithelial
cell injury (19), and biliary bilirubin concentration was measured as marker of hepatocellular
secretory function (19), using standard biochemical methods. Hepatic oxygen consumption
was calculated every 30 minutes during NMP based on the difference between the arterial and
venous oxygen content of the perfusion fluid, as described previously (13). In brief, samples
were taken from the perfusion fluid before and after the liver. Prehepatic samples were taken
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from a side port before the perfusion cannula and posthepatic samples were taken directly
from the suprahepatic vena cava. Hepatic concentration of adenosine triphosphate (ATP) was
used as an indicator of the energy status of grafts during HMP and NMP. For this purpose,
liver tissue biopsies were immediately frozen in liquid nitrogen and were processed later for
ATP measurement, as described previously (13).
Histological Evaluation
Biopsies were taken from the liver parenchyma at the end of SCS and after 6 hours of NMP.
Samples were fixed in 10% formalin and paraffin embedded for further preparation for hema-
toxylin and eosin (H&E) staining. Histological assessment was performed by an expert liver
pathologist, who was not aware of the assigned study groups. To assess preservation injury,
the degree of ischemic necrosis was semi-quantified based on the percentage of necrotic
hepatocytes and categorized as follows: low (60%).
Statistical Analysis
Continuous variables were presented as median with range or interquartile range (IQR). Cate-
gorical variables were presented as number and percentage. Continuous variables were com-
pared between groups using the Mann-Whitney U test. Categorical variables were compared
with the Pearson chi-square or Fischers exact test as appropriate. The level of significance
was set at p-value of <0.05. All statistical analyses were performed using SPSS software
version 22.0 for Windows (SPSS, Inc., Chicago, IL, USA).
RESULTS
Donor Characteristics
A comparison of donor characteristics of livers that received 2 hours of HMP after SCS and
livers that did not undergo HMP after SCS (SCS alone) is provided in Table 1. There were
no significant differences among the donor variables such as donor age, type of donor graft,
donor warm ischemia time (in case of DCD), type of preservation solution, and the ET-DRI.
The median ET-DRI was 3.11 in the HMP group and 2.79 in the SCS only group, illustrating the
poor baseline quality of these donor livers. Moreover, the total preservation time (including 2
hours of HMP) was not significantly different between livers that underwent HMP (11:37 hr:min,
IQR 10:01 - 12:25 hr:min) and livers that only underwent SCS preservation (9:04 hr:min, IQR
7:01 - 11:44 hr:min) prior to viability assessment using NMP.
Vascular Resistance
Changes in vascular resistance of the portal vein and hepatic artery during NMP are presented
in Figure 3A and B. Although the vascular resistance was lower in livers that first underwent
HMP, compared to only SCS preservation, this difference did not reach statistical significance.
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Table 1: Comparison of Donor Characteristics of Livers that Underwent Static Cold Storage
Preservation (SCS) Alone and Livers that Underwent Oxygenated Hypothermic Machine
Perfusion (HMP) after SCS
Variables SCS alone SCS + HMP p-value
Age (years) 61 (52-64) 64 (57-70) 0.21
Gender 0.49
Male 8 (67%) 3 (50%)
Female 4 (33%) 3 (50%)
Length (m) 1.77 (1.67-1.80) 1.75 (1.68-1.79) 0.75
Weight (kg) 88 (76-100) 73 (65-90) 0.08
Body mass index (kg/m2) 27.3 (24.5-36.0) 24.6 (22.6-27.3) 0.10
Type of donor liver 0.18
DCD 9 (75%) 6 (100%)
DBD 3 (25%) 0
Cause of death 0.29
Cardiovascular 2 (16%) 3 (50%)
Post-anoxia 5 (42%) 2 (33%)
Trauma 5 (42%) 1 (17%)
Reasons livers were declined for transplantation 0.29
DCD + age >60 years 5 (42%) 5 (84%)
DCD + high BMI 5 (42%) 1 (17%)
DCD + high transaminases 2 (16%) 0
Latest laboratory value gamma-GT (U/L) 83 (34-130) 30 (19-106) 0.30
Type of preservation solution 0.18
UW solution 9 (75%) 6 (100%)
HTK solution 3 (25%) 0
Time between withdrawal of life support
treatment and circulatory arrest (min)1
20 (4-46) 14 (13-36) 0.61
Time between circulatory arrest and cold flush in
situ (min)1
18 (12-22) 15 (13-23) 0.96
Cold ischemia time (hr: min)2 9:04 (7:01-11:14) 7:18 (6:10-8:32) 0.15
Total preservation time (hr:min)3 9:04 (7:01-11:14) 11:37 (10:01-12:25) 0.10
Eurotransplant - Donor risk index 2.79 (2.24-3.21) 3.11 (2.77-3.39) 0.38
Weight of liver (kg) 2.11 (1.81-2.30) 1.83 (1.15-2.23) 0.29
Data represent median with interquartile ranges for continuous variables or numbers (percentages) for cate-
gorical variables.
Abbreviations: HMP: hypothermic machine perfusion, DCD: donation after circulatory death, DBD: dona-
tion after brain death, SCS: static cold storage, UW: University of Wisconsin, HTK: histidine- tryptophan-
ketoglutarate, BMI: body mass index, gamma-GT: gamma-glutamyl transferase.
1 The total of both time periods can be defined as the total donor warm ischemia time during DCD donation.
2 Time period between cold flush out of the liver in the donor and start of machine perfusion (either HMP or
NMP).
3 Time period between cold flush out of the liver in the donor and start of NMP.
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Evaluation of Hepatobiliary Function
Bile production was used as marker of hepatocellular function and viability (13,20). During
6 hours of NMP, bile production was significantly higher in donor livers that first underwent
HMP, compared to livers that underwent SCS alone (Figure 4A). Moreover, based on the
(cumulative) bile production during NMP, all livers in the HMP group met the criteria for good
functioning livers, whereas only 42% of the livers that underwent SCS alone met these criteria
(Table 2). In both groups, there was no association between the ET-DRI and bile production
during NMP.
The cumulative total biliary bilirubin concentration in the last 30 minutes of NMP was signifi-
cantly higher in the group that underwent HMP, compared to livers that underwent only SCS
preservation (Figure 4B). This finding is compatible with a better hepatocellular secretory
function of livers in the HMP group. Similarly, HMP significantly improved the cumulative bil-
iary bicarbonate secretion in the last 30 minutes of NMP, compared to only SCS preservation
(Figure 4C). Moreover, median biliary pH after 6 hours of NMP was higher in the HMP group
compared to livers that underwent SCS preservation only, but this difference did not reach
statistical significance (Figure 4D).
Concentrations of glucose and lactate in the perfusion fluid during HMP and NMP are pre-
sented in Figure 5. During HMP, a small increase in the levels of glucose and lactate was
observed. During subsequent NMP, glucose and lactate levels were significantly higher in the
SCS group compared to HMP preserved livers. With respect to glucose levels, these levels
normalized in the HMP group (median 11.6 mmol/L), whereas glucose levels in the SCS group
remained elevated after 6 hours of NMP (median 27.5 mmol/L) (p = 0.009) (Figure 5A). In ad-
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Figure 3. Vascular resistance patterns in the portal vein and the hepatic artery during 6 hours of nor-
mothermic machine perfusion (NMP)
During NMP, the vascular resistance in the portal vein and hepatic artery were lower in livers that first underwent
oxygenated hypothermic machine perfusion (HMP) versus livers that underwent static cold storage (SCS) only;
however these differences were not statistically significant. Data are represented as medians with IQR. The error
bar of SCS only group illustrates the range from the median (50th percentile) till the 75 percentile; the error bar
of the HMP group represents the range from the 25 percentile till the median
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in the first hour of NMP (median peak value of 10.1 mmol/L), which was not observed in the
HMP group (median 2.3 mmol/L) (p = 0.002) (Figure 5B). Moreover, to maintain a physiologi-
cal pH, significantly more sodium bicarbonate solution had to be administered to the perfusion
fluid during NMP in the group of livers that underwent SCS only, compared to livers that first
underwent 2 hours of HMP (Table 3).
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Figure 4. Cumulative bile production and biliary composition during 6 hours of normothermic machine
perfusion (NMP)
Panel A: Two hours of oxygenated hypothermic machine perfusion (HMP) resulted in significantly higher bile
production (mL/kg liver) during 6 hours of NMP, compared to SCS only (*p<0.05). In the group with HMP, one
liver was excluded from the analysis because of hemobilia. The error bar of HMP group illustrates the range
between the 50th and 75th percentile; the error bar of the SCS only group represents the range between the 25th
and 50th percentile. Panel B: The cumulative secretion of total bilirubin (total mol) in the last 30 minutes of NMP
was significantly lower in the group with only SCS preservation, compared to livers that first underwent HMP
(*p<0.05). In the group with HMP, one liver was excluded from the analysis because of hemobilia. The Y-axis
is on a logarithmic scale (log 10). Panel C: The cumulative secretion of bicarbonate (HCO3-) (total µmol) in the
last 30 minutes of NMP was significantly higher in the group with HMP, compared to livers that underwent only
SCS preservation (*p<0.05). Panel D: Comparison of biliary pH between the group with HMP and only SCS
preservation, measured at the end of 6 hours NMP. In Panel B, C, and D data are represented as medians with
IQR.
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Evaluation of Hepatobiliary Injury
Release of injury markers during NMP was used to assess the degree of hepatobiliary injury.
To correct for a wash-out effect of HMP, the relative increase in perfusate levels of AST, ALT,
LDH, and gamma-GT during the first 30 minutes and after 6 hours were determined (Table 3).
Except for gamma-GT, during the first 30 minutes of NMP, the relative increase in perfusate
levels of AST, ALT, and LDH were significantly lower in the HMP group compared to the SCS
only group. However, the relative increase in levels of AST, ALT, and LDH between the first 30
minutes and 6 hours of NMP were not significantly different between the two groups, reflecting
a similar level of hepatobiliary injury after 6 hours of NMP (Table 3). Likewise, there were
no significant differences in the biliary concentrations of LDH and gamma-GT after 6 hours of
NMP, indicating that there was no significant difference in cholangiocyte injury (Table 3).
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Figure 5. Perfusion fluid concentrations of glucose and lactate during 2 hours of oxygenated hypother-
mic machine perfusion (HMP) and 6 hours of normothermic machine perfusion (NMP)
Panel A and B: Almost during the entire period of NMP, levels of glucose and lactate were significantly lower
in the group of livers that first underwent 2 hours of HMP, compared to the group with only SCS preservation
(*p<0.05). Data are represented as medians with IQR, except for the levels of lactate in the SCS only group, the
error bars in this group illustrates the range between the 50th and 75th percentile.
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Table 2: Bile Production During Ex Situ Viability Testing Using Normothermic Machine Per-
fusion of Livers that Underwent Static Cold Storage (SCS) Preservation Alone or SCS Fol-






















1 2.5 0.17 0.84 no
2 2.8 0.95 2.02 no
3 3.3 1.26 3.27 no
4 1.4 1.30 3.57 no
5 3.2 1.43 3.86 no
6 3.4 1.48 5.00 no
7 2.2 1.50 5.18 no
8 2.0 2.33 5.91 yes
9 2.5 2.37 7.86 yes
10 3.1 4.86 8.52 yes
11 3.2 5.53 10.20 yes
12 2.8 7.44 15.84 yes
SCS +
HMP
1 2.4 2.67 6.70 yes
2 3.4 4.53 13.76 yes
3 2.9 5.41 15.15 yes
4 3.5 6.09 17.41 yes
5 3.2 21.38 49.05 yes
6# 3.0 - - -
Abbreviations: HMP: hypothermic machine perfusion, SCS: static cold storage, NMP: normothermic machine
perfusion
1 Livers were classified as good functioning according to the following criteria: bile production of more than
2 mL/kg liver between 1.5 2.5 hours of NMP, and cumulative bile production of more than 5 mL/kg liver after
2.5 hours of NMP.
# The collected bile was mixed with blood due to hemobilia. Therefore, this liver was excluded from the
assessment of (cumulative) bile production
Evaluation of Hepatic Energy Status and Oxygen Consumption
Hepatic ATP concentration was used as an indicator of the cellular energy status. Hepatic ATP
content was measured at the end of SCS, during and at the end of HMP and before, during
and at the end of NMP, respectively (Figure 6A). In both groups, all livers were ATP-depleted
at baseline after SCS. The median ATP concentration was 5 µmol/g protein in the HMP group
versus 6.5 µmol/g protein in the SCS only group. During HMP, median ATP concentration
increased >15-fold to 76 µmol/g protein (IQR 48-122 µmol/g protein). After 2 hours of HMP,
while the perfusion fluid was changed, ATP concentration dropped; however, before start of
NMP ATP concentrations were still significantly higher in the HMP group, compared to the
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Table 3: Biochemical Composition of the Perfusion Fluid and Bile during Normothermic
Machine Perfusion (NMP) in the Groups with or without Oxygenated Hypothermic Machine
Perfusion (HMP) after Static Cold Storage Preservation.
Variables SCS only SCS + HMP p-value
(n = 12) (n = 6)
Blood gas parameters
pH 7.35 (7.30-7.40) 7.35 (7.26-7.42) 1.00
pCO2 (kPa)1 6.17 (5.20-6.64) 4.91 (4.57-5.40) 0.05
pO2 (kPa)1 63.9 (56.2-69.2) 70.2 (65.0-78.3) 0.032
sO2 (%)2 99 (98-100) 100 (0.99-100) 0.68
HCO3- (mmol/L) 25.0 (17.6-28.9) 18.7 (17.0-24.5) 0.15
Added NaHCO3 8.4% (mL)2 25.0 (2-50) 3.3 (0-10) 0.041
Injury markers3
AST 0.00-0.50 hrs NMP (U/L) 4073 (2266-10,307) 605 (178-2000) 0.010
AST 0.50 6 hrs NMP (U/L) 4268 (1928-5400) 1730 (173-4210) 0.22
ALT 0.00-0.50 hrs NMP (U/L) 2558 (1236-9671) 688 (109-2133) 0.048
ALT 0.50 6 hrs NMP (U/L) 2397 (3110-952) 775 (100-2090) 0.18
LDH 0.00-0.50 hrs NMP (U/L) 8858 (3526-14,480) 1139 (314-3843) 0.010
LDH 0.50 6 hrs NMP (U/L) 2540 (1939-4189) 1339 (317-3252) 0.21
Gamma-GT 0.00-0.50 hrs NMP (U/L) 51 (21-180) 72 (26-101) 0.80
Gamma-GT 0.50 6 hrs NMP (U/L) 14 (5-34) 51 (0-156) 0.39
Bile contents4
Biliary LDH (mmol/L) 970 (204-1927) 418 (119-1005) 0.43
Biliary gamma-GT (mmol/L) 351 (242-1155) 504 (368-1186) 0.33
Data represent median with interquartile ranges (IQR) for continuous variables
Abbreviations: AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydroge-
nase, gamma-GT: gamma-glutamyl transferase, NaHCO3: sodium bicarbonate, HMP: hypothermic machine
perfusion, SCS: static cold storage
1 To convert kPa to mmHg, multiply by 7.5.
2 Oxygen saturation of hemoglobin
2 Total mL added to the perfusion fluid during 6 hours of NMP.
3 Relative increases in hepatobiliary injury markers during NMP, indicated for the first 0.5 hour (  0.00-0.50
hrs) and 0.5-6 hours of NMP (  0.50-6 hrs).
4 In the HMP group, one liver was excluded from the analysis of bile contents because the collected bile was
mixed with blood due to hemobilia.
SCS only group (15 µmol/g protein in the HMP group versus 6.5 µmol/g protein in the SCS
only group). Moreover, hepatic ATP content increased more rapidly during the first hour of
NMP in livers that first underwent HMP, compared to livers with SCS preservation alone. In
addition, ATP levels in livers that underwent HMP remained significantly higher compared to
SCS only livers during the first 4 hours of NMP. Although not statistically significant, at the end
of 6 hours of NMP, the median hepatic ATP content in the HMP group was 88 µmol/g protein
(IQR: 12-118 µmol/g protein) while it was only 24 µmol/g protein (IQR: 14-51 µmol/g protein)
in the group with only SCS preservation.
In parallel with changes in ATP concentration, the peak value of the oxygen consumption
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during NMP was significantly higher in livers that first underwent HMP (2.9.10-3 mL O2/min/gr
liver) compared to livers with only SCS preservation (1.4.10-3 mL O2/min/gr liver) (Figure 6B).
Histological Assessment
Figure 7 provides histological evaluation of the hepatic biopsies at the end of the regular
period of SCS and after 6 hours NMP viability testing. At baseline, there were no statistical
differences in the degree of ischemic necrosis in both groups. The majority of livers had
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Figure 6. Hepatocellular ATP concentrations and peak oxygen consumption during oxygenated hy-
pothermic machine perfusion (HMP) and normothermic machine perfusion (NMP).
Panel A: In the first 4 hours of NMP, ATP concentrations were significantly higher in the group of livers that un-
derwent HMP, compared to livers that underwent only static cold storage (SCS) preservation (*p<0.05). Data
are represented as medians with IQR, except for the levels of ATP in the SCS only group, the error bars in this
group illustrates the range between the 25th and 50th percentile. Panel B: The peak oxygen consumption (mL
O2/min/gram liver) during NMP was significantly higher in the group with HMP, compared to the group with only
SCS preservation (*p<0.05). Data are represented as medians with IQR.
136



























Figure 7. Comparison of the degree of ischemic necrosis between livers that underwent 2 hours of oxy-
genated hypothermic machine perfusion (HMP) after static cold storage (SCS) and those that underwent
SCS preservation alone, and examples of different grades of ischemic necrosis
Panel A and B: There were no statistical differences in the degree of ischemic necrosis at the end of regular
SCS preservation and after 6 hours of normothermic machine perfusion between the two groups. Panel C and
D: Examples of liver parenchyma without ischemic necrosis. Panel D is a detailed picture of Panel C. Panel E
and F: Grade 1 ischemic necrosis (0-30% of hepatocytes involved). Panel F is a detailed picture of Panel E.
Panel G and H: Ischemic necrosis grade 2 (30-60% of hepatocytes involved). Panel F is a detailed picture of
Panel E. Scale bars in Panels D, F, and H indicate 30 um. Scale bars in Panels C, E, and G indicate 300 µm.
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increase in the amount of ischemic necrosis after NMP in both groups (Figure 7B). Examples
of normal liver parenchyma and different grades of ischemic necrosis are presented in Figure
7, panels C-H. In addition, no major differences between the groups were noticed in the degree
of intrahepatic bile duct injury at the end of 6 hours NMP (Figure 8).
DISCUSSION
The aim of the this study was to assess whether 2 hours of end-ischemic oxygenated HMP
after the regular period of SCS restores hepatobiliary function and reduces injury in human
ECD livers, as assessed during 6 hours of ex situ NMP viability testing. Our study demon-
strated that 2 hours of HMP after traditional SCS significantly improves hepatobiliary function
compared to SCS preservation alone. These improvements in hepatobiliary function are likely
explained by a significant increase in hepatic ATP content during HMP. Although livers that
underwent HMP after SCS displayed better function during NMP, compared to livers that un-
derwent SCS alone, we did not observe significant differences in the amount of hepatobiliary
injury.
The results of this study suggest that the benefit of oxygenated end-ischemic HMP is a result
of a restoration of the oxygen debt and recovery of mitochondrial function prior to warm re-
oxygenation. By providing oxygen, mitochondria are able to generate ATP even if the donor
liver is kept at a low temperature. Our study results support previous experimental studies
using animal models that oxygenated end-ischemic HMP is able to enhance the energy sta-
tus of the cold-stored graft and subsequently improved function after warm reoxygenation
(17,21,22). In our study, HMP enhanced the hepatic ATP content more than 15-fold compared
to values immediately after SCS. Moreover, the ATP levels remained significantly higher dur-
ing the first 4 hours of NMP in the group of livers that underwent HMP compared to livers
that where only preserved by SCS. In parallel with the enhanced ATP levels in livers that un-
Figure 8. Histological comparison of intrahepatic bile duct injury at the end of 6 hours normothermic
machine perfusion (NMP)
There were no differences in the degree of intrahepatic biliary injury between livers that underwent oxygenated
hypothermic perfusion (HMP) after static cold storage (SCS) preservation and livers that underwent SCS alone.
Panel A: example of intrahepatic bile duct in a liver of the SCS only group. Panel B: example of intrahepatic bile
duct in a liver of the HMP group. White arrows point at the intrahepatic bile ducts. Scale bars indicate 20 um.
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derwent HMP, these livers displayed a higher oxygen consumption and produced significantly
more bile, compared to livers that did not undergo HMP. The link between increased bile pro-
duction and higher ATP levels has also been described in porcine livers (20). Bile production
is an energy consuming process and sufficient hepatocellular levels of ATP are needed for the
active secretion of bile acids, bile salts, bilirubin, cholesterol, and other organic molecules into
bile. Similarly, higher levels of biliary bilirubin were noticed in livers that first underwent HMP,
reflecting better hepatocellular function of these livers. Other evidence of improved hepatobil-
iary function after end-ischemic HMP was provided by stable concentrations of glucose and
lactate in the perfusion fluid during NMP. Notably, lactate, which can be seen as a marker of
anaerobic metabolism, did not increase during NMP of livers that first underwent HMP after
SCS, while a clear peak in the lactate concentration was observed in the SCS alone group.
In contrast to the regenerated hepatic ATP and improved functional recovery in livers that first
underwent HMP, we did not observe a reduction in the amount of hepatobiliary injury. There
were no significant differences in the concentration of hepatobiliary injury markers such as
AST, ALT, and LDH in the perfusion fluid at the end of 6 hours NMP between the two study
groups. In parallel with this, there were no significant differences in the histological degree of
hepatic ischemic necrosis at the end of SCS and after 6 hours NMP. Almost 70% of livers in
both groups displayed some degree of ischemic necrosis at baseline. This is not a surprise
as all livers were declined for transplantation and derived from donors with a high ET-DRI.
Moreover, 15 of the 18 livers included in this study were obtained from DCD donors and suf-
fered a donor warm ischemia time of more than 30 min. The combination of suboptimal graft
quality, substantial donor warm ischemia time, and the subsequent period of SCS (median 7-9
hours) can explain the observed hepatocellular injury at baseline. It is obvious that 2 hours of
end-ischemic HMP does not restore preexisting hepatocellular injury; however it does restore
cellular function of the remaining vital parts of the liver.
Next to a better functional recovery of hepatocellular function, we also observed an improved
cholangiocellular function in livers that first underwent HMP. An important aspect of cholangio-
cyte function is the secretion of bicarbonate into bile. Cholangiocytes actively secrete bicar-
bonate to increase biliary pH and protect themselves against the effects of toxic hydrophobic
bile salts. This phenomenon has been described as the biliary bicarbonate umbrella (18,23).
In an alkaline environment, bile salts are deprotonated, which is clinically relevant as pro-
tonated bile salts can passively enter cells by uncontrolled membrane permeation, causing
apoptosis (18,23). Several experimental and clinical studies have shown that bile salt toxic-
ity is associated with the development of NAS after liver transplantation (24-26). Therefore,
the increased secretion of bicarbonate can be seen as an important and promising feature
of end-ischemic HMP in human liver transplantation. In the current study, end-ischemic HMP
was performed using dual perfusion of both the portal vein and the hepatic artery. Bile ducts
are largely dependent on arterial blood supply for the delivery of oxygen and nutrients and we
believe that dual perfusion results in better preservation and functional recovery of the biliary
epithelium than portal vein perfusion alone. It is well known that hepatic artery thrombosis
after transplantation leads to insufficient oxygenation of the biliary epithelium and subsequent
development of ischemic biliary strictures (27). Moreover, in a mouse model, we have previ-
ously shown that complete arterial deprivation results in a loss of bile secretory function and
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subsequent intrahepatic cholestasis (28). In the current study, cholangiocellular bicarbonate
secretion was significantly higher in livers that first underwent HMP. We, therefore, propose
that combined arterial and portal perfusion during HMP has a potential advantage in the post
ischemic recovery of the bile ducts in comparison with single perfusion through the portal vein
alone. However, this still needs to be demonstrated in a separate study comparing single ver-
sus dual liver perfusion.
Another aspect of hepatic HMP that is still not well established is whether the perfusion solu-
tion should be actively oxygenated. Experimental studies in rats have shown that HMP with
100% oxygen results in better functional recovery after ischemia compared with perfusion
with 20% or 0% oxygen (29,30). Advocates of active oxygenation during HMP have claimed
that oxygen is needed to improve mitochondrial function before reperfusion and that perfusion
without oxygen can be seen as only flush out of injury markers (31). On the other hand, pro-
ponents of HMP without oxygen claim that oxygenation increases the risk of oxidative stress
and subsequent injury (31).
It should be noticed that most livers used in this study were obtained from DCD donors. The
only 3 ECD livers that were obtained from a DBD donor coincidentally ended up in the SCS-
only group, and there were no DBD livers in the HMP group. It is well known that DCD livers
have an expected inferior graft quality at baseline after procurement because of the inevitable
warm ischemic period in the donor. The lack of DCD livers in the HMP group, therefore,
could have disadvantaged this group. Nevertheless, our study showed that hepatobiliary func-
tion during ex-situ testing using NMP was significantly better in the group of livers that were
preserved with HMP, compared with the SCS-only group. Therefore, we conclude that the
presence of 3 ECD DBD livers in the HMP group did not have a substantial influence on the
study outcome. If anything, it might have reduced the differences between the 2 groups, and
the real effect of HMP is even larger than we have observed.
The aim of the current study was not to study whether HMP reduces clinical ischemia-
reperfusion injury. Ex-situ NMP was performed with a perfusion fluid consisting of plasma,
red blood cells, and nutrients, but no leukocytes and platelets, with the aim to assess liver
graft viability and function after either SCS or SCS followed by HMP. To examine whether
HMP is not only associated with a restoration of hepatic ATP and hepatobiliary function before
transplantation but also reduces ischemia/reperfusion injury, a clinical trial is needed. With
the favorable results of the current study as basis, we recently initiated a clinical trial in which
end-ischemic HMP is applied in DCD liver transplantation (Dutch Trial Register no. NTR 4493;
www.trialregister.nl). In conclusion, this study demonstrates that a short period of 2 hours of
end-ischemic oxygenated HMP after traditional SCS of ECD livers results in a restoration of in-
trahepatic energy resources. The higher hepatocellular energy levels in livers that underwent
HMP corresponded with a significantly better recovery of hepatobiliary function as assessed
during ex situ NMP, when compared with livers that underwent only SCS preservation. De-
spite this better immediate hepatobiliary function, end-ischemic oxygenated HMP does not
seem to reduce (preexisting) hepatobiliary injury. The beneficial effects of end-ischemic oxy-
genated HMP in this preclinical study provide strong support for further testing end-ischemic
oxygenated HMP in a clinical liver transplant trial.
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